Artemis Investment Management LLP Sells 918,848 Shares of Avantor, Inc. (NYSE:AVTR)

Artemis Investment Management LLP trimmed its holdings in shares of Avantor, Inc. (NYSE:AVTR - Free Report) by 23.7% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,963,239 shares of the company's stock after selling 918,848 shares during the period. Artemis Investment Management LLP owned 0.43% of Avantor worth $48,034,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of the business. Smartleaf Asset Management LLC increased its stake in shares of Avantor by 106.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,611 shares of the company's stock valued at $34,000 after buying an additional 830 shares in the last quarter. Wealthquest Corp bought a new position in shares of Avantor in the first quarter worth about $34,000. Global Retirement Partners LLC lifted its position in shares of Avantor by 76.7% during the fourth quarter. Global Retirement Partners LLC now owns 2,459 shares of the company's stock worth $52,000 after purchasing an additional 1,067 shares in the last quarter. AlphaQuest LLC acquired a new position in shares of Avantor during the fourth quarter worth approximately $65,000. Finally, GAMMA Investing LLC grew its stake in shares of Avantor by 121.6% during the first quarter. GAMMA Investing LLC now owns 3,747 shares of the company's stock valued at $61,000 after purchasing an additional 2,056 shares during the last quarter. Institutional investors own 95.08% of the company's stock.

Avantor Price Performance

Avantor stock opened at $13.76 on Friday. The company has a current ratio of 1.12, a quick ratio of 0.75 and a debt-to-equity ratio of 0.54. The firm has a market capitalization of $9.38 billion, a P/E ratio of 13.23, a PEG ratio of 1.36 and a beta of 1.04. The business has a 50-day moving average of $13.26 and a 200-day moving average of $16.97. Avantor, Inc. has a 1 year low of $11.82 and a 1 year high of $28.00.

Avantor (NYSE:AVTR - Get Free Report) last issued its earnings results on Friday, April 25th. The company reported $0.23 EPS for the quarter, meeting the consensus estimate of $0.23. The firm had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.61 billion. Avantor had a net margin of 10.70% and a return on equity of 11.93%. The business's quarterly revenue was down 5.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.22 earnings per share. On average, equities analysts anticipate that Avantor, Inc. will post 1.06 EPS for the current year.

Analyst Upgrades and Downgrades

AVTR has been the subject of several research analyst reports. Robert W. Baird dropped their price objective on shares of Avantor from $21.00 to $17.00 and set an "outperform" rating for the company in a research report on Monday, April 28th. Citigroup dropped their target price on Avantor from $22.00 to $18.00 and set a "neutral" rating for the company in a research report on Tuesday, March 4th. TD Cowen lowered Avantor from a "buy" rating to a "hold" rating and set a $15.50 price target on the stock. in a research note on Monday, April 28th. Stifel Nicolaus lowered Avantor from a "buy" rating to a "hold" rating and lowered their price objective for the stock from $26.00 to $14.00 in a research report on Monday, April 28th. Finally, Royal Bank Of Canada dropped their price objective on Avantor from $24.00 to $20.00 and set an "outperform" rating for the company in a report on Monday, April 28th. Seven equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $18.88.

Insider Transactions at Avantor

In related news, Director Joseph R. Massaro acquired 8,100 shares of the stock in a transaction dated Tuesday, April 29th. The stock was bought at an average price of $12.30 per share, with a total value of $99,630.00. Following the completion of the transaction, the director now directly owns 35,038 shares of the company's stock, valued at approximately $430,967.40. The trade was a 30.07% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Gregory L. Summe bought 30,000 shares of Avantor stock in a transaction that occurred on Friday, May 23rd. The stock was bought at an average cost of $12.50 per share, with a total value of $375,000.00. Following the completion of the purchase, the director now owns 100,000 shares in the company, valued at approximately $1,250,000. This trade represents a 42.86% increase in their position. The disclosure for this purchase can be found here. Insiders have acquired a total of 83,100 shares of company stock valued at $1,027,630 over the last 90 days. 1.20% of the stock is owned by company insiders.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.